Neurocrine Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 13.39 M | $1.76 B | 4.33% | 13.45% |
| DODGE & COX | 05/14/2026 | 5.46 M | $719.44 M | -0.85% | 5.49% |
| JPMORGAN CHASE & CO | 05/13/2026 | 5.44 M | $700.50 M | 4.65% | 5.47% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 4.94 M | $650.66 M | 50.96% | 4.96% |
| 05/08/2026 | 4.73 M | $622.65 M | 100.00% | 4.75% | |
| 05/15/2026 | 4.51 M | $594.40 M | 100.00% | 4.53% | |
| STATE STREET CORP | 05/15/2026 | 4.35 M | $573.67 M | 2.64% | 4.38% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 3.06 M | $403.20 M | 210.78% | 3.08% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 2.42 M | $318.67 M | 8.04% | 2.43% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.14 M | $280.80 M | 3.76% | 2.15% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2026 | 1.49 M | $196.77 M | 7.01% | 1.50% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 1.39 M | $183.06 M | -20.35% | 1.40% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 1.25 M | $164.68 M | 100.00% | 1.26% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.25 M | $164.34 M | 181.68% | 1.25% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.24 M | $163.73 M | 1.77% | 1.25% |
| UBS GROUP AG | 05/05/2026 | 1.22 M | $160.86 M | 24.15% | 1.23% |
| MORGAN STANLEY | 05/15/2026 | 1.22 M | $160.62 M | 0.81% | 1.23% |
| RTW INVESTMENTS, LP | 05/15/2026 | 1.06 M | $139.92 M | 0.00% | 1.07% |
| FIRST TRUST ADVISORS LP | 05/13/2026 | 959.22 K | $126.37 M | 97.04% | 0.96% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 902.79 K | $118.93 M | 6.13% | 0.91% |
| IEQ CAPITAL, LLC | 05/15/2026 | 765.98 K | $100.91 M | 2.80% | 0.77% |
| VICTORY CAPITAL MANAGEMENT INC | 05/15/2026 | 731.61 K | $96.38 M | 487.35% | 0.74% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 724.00 K | $95.38 M | -11.73% | 0.73% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 711.76 K | $93.75 M | -0.66% | 0.72% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 702.49 K | $92.55 M | -4.90% | 0.71% |
| BRAIDWELL LP | 05/15/2026 | 652.12 K | $85.91 M | -13.23% | 0.66% |
| FIERA CAPITAL CORP | 05/12/2026 | 651.26 K | $85.80 M | 2.17% | 0.65% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 634.34 K | $83.57 M | 100.00% | 0.64% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 611.26 K | $80.53 M | 14.74% | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 610.00 K | $80.36 M | -48.49% | 0.61% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 602.64 K | $78.94 M | -22.43% | 0.61% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 601.49 K | $78.32 M | -4.74% | 0.60% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/13/2026 | 593.73 K | $78.22 M | 2.96% | 0.60% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 583.83 K | $76.91 M | 10.55% | 0.59% |
| SWEDBANK AB | 04/29/2026 | 579.43 K | $76.33 M | -0.80% | 0.58% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/13/2026 | 571.72 K | $75.32 M | -20.87% | 0.57% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2026 | 523.53 K | $74.25 M | -5.75% | 0.53% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 520.27 K | $68.54 M | 1,389.63% | 0.52% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 512.03 K | $67.46 M | -12.57% | 0.51% |
| MARSHALL WACE, LLP | 05/15/2026 | 508.98 K | $67.05 M | 45.90% | 0.51% |
| PRIMECAP MANAGEMENT CO/CA/ | 05/11/2026 | 496.34 K | $65.39 M | -2.25% | 0.50% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 487.95 K | $64.28 M | 132.68% | 0.49% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 466.98 K | $61.52 M | 1.70% | 0.47% |
| NUVEEN, LLC | 04/30/2026 | 443.05 K | $58.37 M | 54.49% | 0.45% |
| MAN GROUP PLC | 05/15/2026 | 415.91 K | $54.79 M | 79.88% | 0.42% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2026 | 404.39 K | $53.27 M | 3.88% | 0.41% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 395.85 K | $52.15 M | 29.79% | 0.40% |
| LEGAL & GENERAL GROUP PLC | 05/08/2026 | 380.59 K | $50.14 M | 15.12% | 0.38% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 365.35 K | $48.13 M | -0.71% | 0.37% |
| GOTHAM ASSET MANAGEMENT, LLC | 05/15/2026 | 360.14 K | $47.44 M | 113.64% | 0.36% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurocrine Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 980 institutional investors and hedge funds held shares of Neurocrine Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 13.39 M
DODGE & COX: 5.46 M
JPMORGAN CHASE & CO: 5.44 M
AQR CAPITAL MANAGEMENT LLC: 4.94 M
STATE STREET CORP: 4.35 M
TWO SIGMA INVESTMENTS, LP: 3.06 M
100.43% of Neurocrine Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 142.31 M shares in the last 24 months. This purchase volume represents approximately $18.49 B in transactions.